cabergoline has been researched along with Infections, Coronavirus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dekkers, OM; Fleseriu, M; Karavitaki, N | 1 |
1 other study(ies) available for cabergoline and Infections, Coronavirus
Article | Year |
---|---|
Endocrinology in the time of COVID-19: Management of pituitary tumours.
Topics: Adenoma; Antineoplastic Agents, Hormonal; Cabergoline; Coronavirus Infections; COVID-19; Disease Management; Dopamine Agonists; Hormone Replacement Therapy; Human Growth Hormone; Humans; Neurosurgical Procedures; Octreotide; Pandemics; Peptides, Cyclic; Pituitary Apoplexy; Pituitary Neoplasms; Pneumonia, Viral; Practice Guidelines as Topic; Radiotherapy; Somatostatin; Telemedicine; Time Factors; Visual Field Tests | 2020 |